Anti-MYL6B monoclonal antibody

Pre-made anti-MYL6B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MYL6B/MYL6B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1226-Ab-1/ GM-Tg-hg-IP1226-Ab-2Anti-Human MYL6B monoclonal antibodyHuman
GM-Tg-rg-IP1226-Ab-1/ GM-Tg-rg-IP1226-Ab-2Anti-Rat MYL6B monoclonal antibodyRat
GM-Tg-mg-IP1226-Ab-1/ GM-Tg-mg-IP1226-Ab-2Anti-Mouse MYL6B monoclonal antibodyMouse
GM-Tg-cynog-IP1226-Ab-1/ GM-Tg-cynog-IP1226-Ab-2Anti-Cynomolgus/ Rhesus macaque MYL6B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1226-Ab-1/ GM-Tg-felg-IP1226-Ab-2Anti-Feline MYL6B monoclonal antibodyFeline
GM-Tg-cang-IP1226-Ab-1/ GM-Tg-cang-IP1226-Ab-2Anti-Canine MYL6B monoclonal antibodyCanine
GM-Tg-bovg-IP1226-Ab-1/ GM-Tg-bovg-IP1226-Ab-2Anti-Bovine MYL6B monoclonal antibodyBovine
GM-Tg-equg-IP1226-Ab-1/ GM-Tg-equg-IP1226-Ab-2Anti-Equine MYL6B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1226-Ab-1/ GM-Tg-hg-IP1226-Ab-2; GM-Tg-rg-IP1226-Ab-1/ GM-Tg-rg-IP1226-Ab-2;
GM-Tg-mg-IP1226-Ab-1/ GM-Tg-mg-IP1226-Ab-2; GM-Tg-cynog-IP1226-Ab-1/ GM-Tg-cynog-IP1226-Ab-2;
GM-Tg-felg-IP1226-Ab-1/ GM-Tg-felg-IP1226-Ab-2; GM-Tg-cang-IP1226-Ab-1/ GM-Tg-cang-IP1226-Ab-2;
GM-Tg-bovg-IP1226-Ab-1/ GM-Tg-bovg-IP1226-Ab-2; GM-Tg-equg-IP1226-Ab-1/ GM-Tg-equg-IP1226-Ab-2
Products NameAnti-MYL6B monoclonal antibody
Formatmab
Target NameMYL6B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MYL6B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1226-Ag-1Recombinant multi-species MYL6B/ MLC1SA protein


    Target information

    Target IDGM-IP1226
    Target NameMYL6B
    Gene ID140465,216459,106992272,606992,101095991,515421,100059367
    Gene Symbol and Synonyms5730437E04Rik,MLC1SA,MYL6B
    Uniprot AccessionP14649
    Uniprot Entry NameMYL6B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000196465
    Target ClassificationN/A

    The target: MYL6B, gene name: MYL6B, also named as MLC1SA. Myosin is a hexameric ATPase cellular motor protein. It is composed of two heavy chains, two nonphosphorylatable alkali light chains, and two phosphorylatable regulatory light chains. This gene encodes a myosin alkali light chain expressed in both slow-twitch skeletal muscle and in nonmuscle tissue. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.